Contineum Therapeutics, Inc. — insider transactions
6 transactions on record · CTNM · CIK 1855175
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
6
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$17.7K
Median disclosure lag
1.5 d
trade date to filing date
Largest single trade, 24m
$16.2K
2026-07-08
Director share, 12m
0.0%
of transactions where role is stated
Current run
6 sells
consecutive same-direction transactions
Net 3m flow
-$17.7K
purchases minus sales
Total on record
6
Transactions
6 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-08 | 2 | Lorrain Daniel S. | Chief Scientific Officer | Exercise of derivative | 1,015 | $1.01 | $1K | filing |
| 2026-07-10 | 2026-07-09 | 1 | Lorrain Daniel S. | Chief Scientific Officer | Open market sale | 25 | $16.00 | $400 | filing |
| 2026-07-10 | 2026-07-09 | 1 | Lorrain Daniel S. | Chief Scientific Officer | Exercise of derivative | 25 | $1.01 | $25.3 | filing |
| 2026-07-10 | 2026-07-09 | 1 | Lorrain Daniel S. | Chief Scientific Officer | Exercise of derivative | 25 | $0.00 | — | filing |
| 2026-07-10 | 2026-07-08 | 2 | Lorrain Daniel S. | Chief Scientific Officer | Open market sale | 1,015 | $16.00 | $16.2K | filing |
| 2026-07-10 | 2026-07-08 | 2 | Lorrain Daniel S. | Chief Scientific Officer | Exercise of derivative | 1,015 | $0.00 | — | filing |